TELA - TELA Bio, Inc.

0.78
-0.020   -2.526%

Share volume: 90,870
Last Updated: 04-28-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.05%

PREVIOUS CLOSE
CHG
CHG%
$0.80
-0.02
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
41%
Profitability 33%
Dept financing 25%
Liquidity 75%
Performance 45%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
16.42%
1 Month
38.08%
3 Months
-19.70%
6 Months
-40.91%
1 Year
-17.03%
2 Year
-82.74%
Key data
Stock price
$0.78
P/E Ratio 
N/A
DAY RANGE
$0.76 - $0.82
EPS 
-$0.78
52 WEEK RANGE
$0.50 - $2.20
52 WEEK CHANGE
-$19.59
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
44.740 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
-0.01
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$200,696
AVERAGE 30 VOLUME 
$181,396
Company detail
CEO: Antony Koblish
Region: US
Website: telabio.com
Employees: 120
IPO year: 2019
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

TELA Bio, Inc. focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company markets its products through a single direct sales force, principally in the United States.

Recent news